|
1
|
Gabriel SE and Michaud K: Epidemiological
studies in incidence, prevalence, mortality, and comorbidity of the
rheumatic diseases. Arthritis Res Ther. 11:2292009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yilmaz S and Simek I: Early intervention
in the treatment of rheumatoid arthritis: focus on tocilizumab.
Ther Clin Risk Manag. 9:403–408. 2013.PubMed/NCBI
|
|
3
|
Mor A, Abramson SB and Pillinger MH: The
fibroblast-like synovial cell in rheumatoid arthritis: a key player
in inflammation and joint destruction. Clin Immunol. 115:118–128.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huber LC, Distler O, Tarner I, Gay RE, Gay
S and Pap T: Synovial fibroblasts: key players in rheumatoid
arthritis. Rheumatology (Oxford). 45:669–675. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parada-Turska J, Nowicka-Stążka P, Majdan
M, Jabłoński M, Turski WA and Rzeski W: Anti-epileptic drugs
inhibit viability of synoviocytes in vitro. Ann Agric Environ Med.
20:571–574. 2013.PubMed/NCBI
|
|
7
|
Pincus T, Kavanaugh A and Sokka T:
Benefit/risk of therapies for rheumatoid arthritis: underestimation
of the ‘side effects’ or risks of RA leads to underestimation of
the benefit/risk of therapies. Clin Exp Rheumatol. 22(Suppl 35):
S2–S11. 2004.PubMed/NCBI
|
|
8
|
Lu HM, Liang YZ, Yi LZ and Wu XJ:
Anti-inflammatory effect of Houttuynia cordata injection. J
Ethnopharmacol. 104:245–249. 2006. View Article : Google Scholar
|
|
9
|
Miyata M, Koyama T and Yazawa K: Water
extract of Houttuynia cordata Thunb. leaves exerts
anti-obesity effects by inhibiting fatty acid and glycerol
absorption. J Nutr Sci Vitaminol (Tokyo). 56:150–156. 2010.
|
|
10
|
Hayashi K, Kamiya M and Hayashi T:
Virucidal effects of the steam distillate from Houttuynia
cordata and its components on HSV-1, influenza virus, and HIV.
Plant Med. 61:237–241. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang JS, Chiang LC, Chen CC, Liu LT, Wang
KC and Lin CC: Antileukemic activity of Bidens pilosa L.
var. minor (Blume) Sherff and Houttuynia cordata Thunb. Am J
Chin Med. 29:303–312. 2001.
|
|
12
|
Yang F, Ren L, Xiong Z, et al: Enterovirus
71 outbreak in the People’s Republic of China in 2008. J Clin
Microbiol. 47:2351–2352. 2009.
|
|
13
|
Chen X, Wang C, Xu L, et al: A laboratory
evaluation of medicinal herbs used in China for the treatment of
hand, foot, and mouth disease. Evid Based Complement Alternat Med.
2013:5045632013.PubMed/NCBI
|
|
14
|
Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT,
Wong WR and Horng JT: Anti-enterovirus 71 activity screening of
Chinese herbs with anti-infection and inflammation activities. Am J
Chin Med. 37:143–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau KM, Lee KM, Koon CM, et al:
Immunomodulatory and anti-SARS activities of Houttuynia
cordata. J Ethnopharmacology. 118:79–85. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Wang R, Zhang Y, Zhang X, Layon AJ,
Li Y and Chen M: Symptom combinations associated with outcome and
therapeutic effects in a cohort of cases with SARS. Am J Chin Med.
34:937–947. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Wang Z, Yang Z, Wang J, Xu Y, Tan
RX and Li E: Houttuynia cordata blocks HSV infection through
inhibition of NF-κB activation. Antiviral Res. 92:341–345. 2011.
View Article : Google Scholar
|
|
18
|
Liu G, Xiang H, Tang X, et al:
Transcriptional and functional analysis shows sodium
houttuyfonate-mediated inhibition of autolysis in Staphylococcus
aureus. Molecules. 16:8848–8865. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan P, Wang YJ, Han L, Liu X, Zhao M and
Yuan YF: Effects of sodium houttuyfonate on expression of NF-κB and
MCP-1 in membranous glomerulonephritis. J Ethnopharmacology.
131:203–209. 2010.PubMed/NCBI
|
|
20
|
Shin S, Joo SS, Jeon JH, et al:
Anti-inflammatory effects of a Houttuynia cordata
supercritical extract. J Vet Sci. 11:273–275. 2010. View Article : Google Scholar
|
|
21
|
Choy EH and Panayi GS: Cytokine pathways
and joint inflammation in rheumatoid arthritis. N Engl J Med.
344:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feldmann M: Development of anti-TNF
therapy for rheumatoid arthritis. Nat Rev Immunol. 2:364–371. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maini RN: Anti-TNF therapy from the bench
to the clinic: a paradigm of translational research. Clin Med.
10:161–162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee HJ, Seo HS, Kim GJ, et al:
Houttuynia cordata Thunb inhibits the production of
pro-inflammatory cytokines through inhibition of the NFκB signaling
pathway in HMC-1 human mast cells. Mol Med Rep. 8:731–736.
2013.
|
|
25
|
Maini RN and Taylor PC: Anti-cytokine
therapy for rheumatoid arthritis. Annu Rev Med. 51:207–229. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chu K, Zheng H, Li H, Zhang Y, Zhang X, Xu
W and Chen L: Shuangtengbitong tincture treatment of
collagen-induced arthritis via downregulation of the expression of
IL-6, IL-8, TNF-α and NF-κB. Exp Ther Med. 5:423–428.
2013.PubMed/NCBI
|
|
27
|
Weinblatt ME, Keystone EC, Furst DE, et
al: Adalimumab, a fully human anti-tumor necrosis factor alpha
monoclonal antibody, for the treatment of rheumatoid arthritis in
patients taking concomitant methotrexate: the ARMADA trial.
Arthritis Rheum. 48:35–45. 2003. View Article : Google Scholar
|
|
28
|
Park E, Kum S, Wang C, Park SY, Kim BS and
Schuller-Levis G: Anti-inflammatory activity of herbal medicines:
inhibition of nitric oxide production and tumor necrosis
factor-alpha secretion in an activated macrophage-like cell line.
Am J Chin Med. 33:415–424. 2005. View Article : Google Scholar
|
